Literature DB >> 12377185

Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat.

Ghislaine Duisit1, Hervé Conrath, Sylvie Saleun, Sebastien Folliot, Nathalie Provost, François-Loïc Cosset, Virginie Sandrin, Philippe Moullier, Fabienne Rolling.   

Abstract

The purpose of our study was to evaluate lentiviral vector-mediated rat retinal transduction using simian immunodeficiency virus (SIV) pseudotyped with envelope proteins from vesicular stomatitis virus G glycoprotein (VSV-G), Mokola virus G protein (MK-G), amphotropic murine leukemia virus envelope (4070A-Env), influenza A virus hemagglutinin (HA), lymphocytic choriomeningitis virus G protein (LCMV-G), and RD114 retrovirus envelope (RD114-Env). The six pseudotyped lentivirus vectors carried CMV-driven green fluorescent protein (GFP) or beta-galactosidase (beta-gal) reporter genes. Intravitreal and subretinal injections of each pseudotyped recombinant SIV were performed in cohorts of Wistar rats. Our results showed that no transgene expression was detected after intravitreal injection of each pseudotyped SIV vector. Also, no transduction could be detected following subretinal injection of RD114 pseudotyped SIV vectors. However, selective transduction of retinal pigment epithelium (RPE) cells was repeatedly obtained after subretinal delivery of VSV-G, MK-G, 4070A-Env, HA, and LCMV-G pseudotyped SIV. GFP expression was maximum as soon as 4 days postadministration for VSV-G, MK-G, 4070A-Env, and HA pseudotypes, with no evidence of pseudotransduction for VSV-G. Maximum transgene expression was observed 3 weeks postinjection for LCMV-6. Importantly, HA and VSV-G pseudotyped SIV lead to such a high level of transgene expression that GFP-related toxicity occurred. Therefore, when a high level of GFP synthesis is achieved, replacement of enhanced GFP (egfp, Aequorea victoria) by a low-toxicity GFP (Renilla reniformis) cDNA is necessary to allow long-term expression.

Entities:  

Mesh:

Year:  2002        PMID: 12377185     DOI: 10.1006/mthe.2002.0690

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  17 in total

1.  AAV gene transfer to the retina does not protect retrovirally transduced hepatocytes from the immune response.

Authors:  Marta Bellodi-Privato; Guylène Le Meur; Dominique Aubert; Alexandra Mendes-Madera; Virginie Pichard; Fabienne Rolling; Nicolas Ferry
Journal:  J Mol Med (Berl)       Date:  2004-03-24       Impact factor: 4.599

Review 2.  Let There Be Light: Gene and Cell Therapy for Blindness.

Authors:  Deniz Dalkara; Olivier Goureau; Katia Marazova; José-Alain Sahel
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

Review 3.  Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients.

Authors:  Pasqualina Colella; Alberto Auricchio
Journal:  Hum Gene Ther       Date:  2012-08       Impact factor: 5.695

4.  Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.

Authors:  Patrick L Sinn; Erin R Burnight; Melissa A Hickey; Gary W Blissard; Paul B McCray
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes.

Authors:  Sabine Steffens; Jessica Tebbets; Christof M Kramm; Dirk Lindemann; Alan Flake; Miguel Sena-Esteves
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

6.  Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.

Authors:  Kenneth P Greenberg; Scott F Geller; David V Schaffer; John G Flannery
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-04       Impact factor: 4.799

7.  Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants.

Authors:  Dyana T Saenz; Nils Loewen; Mary Peretz; Todd Whitwam; Román Barraza; Kyle G Howell; Jonathan M Holmes; Margaret Good; Eric M Poeschla
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Functional promoter testing using a modified lentiviral transfer vector.

Authors:  Scott F Geller; Phillip S Ge; Meike Visel; Kenneth P Greenberg; John G Flannery
Journal:  Mol Vis       Date:  2007-05-17       Impact factor: 2.367

Review 9.  Vector platforms for gene therapy of inherited retinopathies.

Authors:  Ivana Trapani; Agostina Puppo; Alberto Auricchio
Journal:  Prog Retin Eye Res       Date:  2014-08-12       Impact factor: 21.198

10.  Gene delivery to pancreatic exocrine cells in vivo and in vitro.

Authors:  Isabelle Houbracken; Luc Baeyens; Philippe Ravassard; Harry Heimberg; Luc Bouwens
Journal:  BMC Biotechnol       Date:  2012-10-22       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.